12:00 AM
Nov 16, 2009
 |  BC Week In Review  |  Clinical News  |  Regulatory

Afluria regulatory update

FDA granted accelerated approval to expand the label for CSL's Afluria trivalent inactivated seasonal influenza vaccine and Influenza A/H1N1 2009 vaccine...

Read the full 81 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >